Role of bortezomib combined with aerobic oxidation inhibitor oligomycin in suppressing proliferation of Burkitt lymphoma cell line Raji
Xia SHAO,Jiayi CAI,Biyu XU,Jihua ZHONG,Fangyuan CHEN,Ting WANG
DOI: https://doi.org/10.3781/j.issn.1000-7431.2016.11.950
2016-01-01
Tumori
Abstract:Objective: To investigate the effect of bortezomib (BTZ) in combination with aerobic oxidation inhibitor oligomycin (OM) on proliferation and apoptosis of Burkitt lymphoma cell line Raji, and to explore its possible molecular mechanism.Methods: Raji cells were treated with different concentrations of BTZ (0, 5, 10, 15, 20, 25 and 30 nmol/L) alone or in combination with OM (0.05 µg/mL). Cell proliferation was detected by CCK-8 method. The mRNA and protein expression levels of oncogene C-myc, hypoxia-inducible factor-1α (HIF-1α) and its target genes vascular endothelial growth factor (VEGF) and glucose transporter 1 (GLUT1), and key enzymes and proteins related to glycolysis pathway including hexokinase Ⅱ (HKⅡ), lactic dehydrogenase (LDHA) and succinate dehydrogenase (SDHA) were detected by real-time fluorescent quantitative PCR and Western blotting, respectively. Glucose consumption and lactic acid generation were examined by Glucose (hexokinase, HK) Assay Kit and Lactate Assay Kit, respectively. Apoptosis and cell cycle distribution were analyzed by FCM.Results: The result of CCK-8 method showed that treatment with different concentrations of BTZ could inhibit the proliferation of Raji cells in a dose-dependent manner (all P u003c 0.01), the inhibition effect was significantly enhanced at lower initial concentrations of BTZ (5, 10, 15 and 20 nmol/L) in combination with OM (all P u003c 0.01). The expression levels of C-myc, HIF-1α, VEGF, GLUT1, HKⅡ, LDHA and SDHA mRNAs and proteins were suppressed by BTZ, and the expression levels were further down-regulated due to treatment with BTZ in combination with OM (all P u003c 0.05). The inhibition of glucose consumption and lactic acid generation induced by BTZ in combination with OM was significantly enhanced as compared with those induced by BTZ alone (both P u003c 0.05). The result of FCM showed that BTZ could induce apoptosis of Raji cells in a dose-dependent manner, and the cell cycle was arrested in G2/M phase under a relatively high concentration of BTZ (25 nmol/L). Furthermore, when BTZ was used in combination with aerobic oxidation inhibitor OM, significant synergistic effect was observed; besides, the cell cycle was arrested at G0/G1 phase instead.Conclusion: BTZ can hinder the glycolysis pathway in Burkitt lymphoma cell line Raji, which can also be enhanced by the involvement of aerobic oxidation inhibitor OM, known as a synergistic inhibitor. The mechanism of this synergy may be interpreted as inhibiting the dual metabolic pathway, namely glycolysis and aerobic oxidation. This inhibition of dual metabolic pathway may imply a novel approach to treatment of Burkitt lymphoma. DOI:10.3781/j.issn.1000-7431.2016.11.950